Niagen Bioscience (NAGE) Receivables: 2011-2025
Historic Receivables for Niagen Bioscience (NAGE) over the last 13 years, with Sep 2025 value amounting to $8.5 million.
- Niagen Bioscience's Receivables rose 19.87% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.1 million, marking a year-over-year increase of 23.63%. This contributed to the annual value of $7.8 million for FY2024, which is 48.41% up from last year.
- Niagen Bioscience's Receivables amounted to $8.5 million in Q3 2025, which was down 12.31% from $9.7 million recorded in Q2 2025.
- Niagen Bioscience's 5-year Receivables high stood at $12.7 million for Q1 2023, and its period low was $5.2 million during Q4 2023.
- In the last 3 years, Niagen Bioscience's Receivables had a median value of $7.1 million in 2025 and averaged $7.7 million.
- As far as peak fluctuations go, Niagen Bioscience's Receivables skyrocketed by 103.84% in 2021, and later plummeted by 54.81% in 2023.
- Niagen Bioscience's Receivables (Quarterly) stood at $7.3 million in 2021, then spiked by 58.09% to $11.6 million in 2022, then slumped by 54.81% to $5.2 million in 2023, then skyrocketed by 48.41% to $7.8 million in 2024, then increased by 19.87% to $8.5 million in 2025.
- Its Receivables stands at $8.5 million for Q3 2025, versus $9.7 million for Q2 2025 and $7.1 million for Q1 2025.